Clomiphene Citrate for Male Secondary Hypogonadism

Introduction to Clomiphene Citrate

• The European Association of Urology recommends clomiphene citrate as an alternative to exogenous testosterone for stimulating endogenous production in men with secondary hypogonadism, particularly when fertility preservation is desired 1
• The American Urological Association and the American Society for Reproductive Medicine note that selective estrogen receptor modulators like clomiphene may be used in non-obstructive azoospermia prior to surgical intervention 2

Clinical Scenarios for Clomiphene Use

• Clomiphene is the preferred first-line treatment for men actively seeking fertility or wishing to preserve future fertility potential, as it stimulates endogenous testosterone production without suppressing spermatogenesis 2, 3, 4

Dosing and Monitoring

• The standard regimen for clomiphene citrate is 25-50 mg orally three times weekly, as recommended by the European Association of Urology 1

Predictors of Response and Contraindications

• Men with primary hypogonadism (elevated LH/FSH) are absolutely contraindicated for clomiphene, as they cannot respond to gonadotropin stimulation and require testosterone replacement 3, 4

Comparison with Testosterone Therapy

• Clomiphene offers distinct advantages over testosterone therapy, including preservation of fertility, no risk of erythrocytosis, maintenance of testicular volume, and lower cost 2, 3, 4